Theranib Inc.
- Biotech or pharma, therapeutic R&D
Theranib Inc., is a biotechnology startup pioneering precision medicine-based cancer therapies targeting ALDH1A3, a key driver of tumor growth and metastasis. Its innovative approach combines a first-in-class small molecule drug, paired with a biomarker assay to identify patients most likely to benefit, ensuring high efficacy and minimal side effects.
With preclinical studies demonstrating in vivo efficacy, Theranib offers a transformative solution for patients with metastatic cancers such as breast, lung, and melanoma and difficult-to-treat cancers like glioblastoma.
We are now looking for investors and partners that will enable us to complete investigational new drug (IND)-filing studies and initiate a Phase I trial.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}